相关实验视频

Updated: Jun 29, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

多发性硬化症第1部分:基本知识和麦当劳标准

Sonia Gill¹, Mohit Agarwal¹

¹Section of Neuroradiology, Medical College of Wisconsin, Milwaukee, USA.

Magnetic resonance imaging clinics of North America

|March 30, 2024

概括

多发性硬化症是一种炎症性中枢神经系统疾病. 磁共振成像 (MRI) 通过评估中枢神经系统的病变,对诊断多发性硬化至关重要.

科学领域:

神经学神经学
神经免疫学神经免疫学
放射学放射学是一门学科.

背景情况:

多发性硬化症 (MS) 是一种炎症性脱髓化疾病,影响中枢神经系统 (CNS).
它呈现出复发性缓解性或渐进性神经症状和特征性的白质病变.
疾病进展的标志是病变在空间和时间上的传播.

研究的目的:

突出磁共振成像 (MRI) 在多发性硬化症中的诊断和预后作用.
强调评估整个中枢神经系统对MS诊断的重要性.
为了强调在确诊之前排除MS模仿者的必要性.

主要方法:

对多发性硬化症的当前诊断标准的审查.
评估磁共振成像 (MRI) 作为MS的生物标志物.
对MS的差异诊断的讨论.

主要成果:

多发性硬化症的标志是病变在空间和时间的传播,根据麦克唐纳标准定义.
在MS患者中,MRI是评估整个中枢神经系统的重要工具.
排除模仿MS的其他疾病是一个关键的诊断步骤.

结论:

核磁共振是多发性硬化症的诊断和预后不可或缺的.
综合性中枢神经系统评估使用MRI助力精确的MS诊断.
不同诊断对于确认多发性硬化症和排除模仿症至关重要.

关键词:

脱叶林性疾病是一种脱叶林性疾病.图像推建议图像推这就是为什么MRI是MRI.麦当劳的标准麦当劳的标准多发性硬化症是多发性硬化症.多发性硬化症模仿多发性硬化症

更多相关视频

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...